Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
PROVECTUS BIOPHARMACEUTICALS, INC. | Director | Series D-1 Convertible Preferred Stock | 159K | Sep 30, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Sep 30, 2024 | 1 | $0 | 4 | Sep 30, 2024 | Director |
PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | Jun 17, 2021 | 3 | $0 | 4 | Jun 22, 2021 | Director |